Prevalence of erectile dysfunction in thyroid disorders: Comparison with control subjects and with obese and diabetic patients

International Journal of Impotence Research

Volumn 18, Issue 1, 2006, Pages 111-114

  Veronelli, A ^a   Masu, A ^a   Ranieri, R ^a   Rognoni, C ^a   Laneri, M ^a   Pontiroli, A E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Age; Diabetes mellitus; Erectile dysfunction; Obesity; Quality of life; Thyroid

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; THYROID DISEASE;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; IMPOTENCE; MALE; OBESITY; PREVALENCE; THYROID DISEASES;

EID: 30044441008     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901364     Document Type: Article

References (28)

1. NIH Consensus Development Panel on Impotence. NIH consensus conference: impotence. JAMA 1993; 270: 83-90.
2. Bortolotti A, Perazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323-334.
3. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin N Am 1995; 22: 699-709.
4. Mulligan T, Retchin SM, Chinchilli VM, Bettinger CB. The role of aging and chronic disease in sexual dysfunction. J Am Geriatr Soc 1988; 36: 520-524.
5. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachussetts Male Aging Study. J Urol 1994; 151: 54-61.
6. Mak R, De Baker G, Kornitzer M, De Meyer JM. Prevalence and correlates of erectile dysfunction in a population-based study in Belgium. Eur Urol 2002; 41: 132-138.
7. Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C, Murino M, Thonneau P. Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002; 42: 382-389.
8. Furlow WL. Prevalence of impotence in the United States. Med Asp Hum Sex 1985; 19: 13-16.
9. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 26: 181-184.
10. Wabrek AJ, Burchell RC. Male sexual dysfunction associated with coronary heart disease. Arch Sex Behav 1980; 9: 69-75.
11. Bansal S. Sexual dysfunction in hypertensive men. Hypertension 1988; 12: 1-10.
12. Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E et al. Gruppo Italiano Deficit Erettile Diabetici. Erectile dysfunction in type 1 and type 2 diabetics in Italy. Int J Epidemiol 2000; 29: 524-531.
13. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802-1813.
14. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980; 18: 279-283.
15. Rubin A, Babbott B. Impotence and diabetes mellitus. JAMA 1958; 168: 498-500.
16. Brunner GA, Pieber TR, Schattenberg S, Ressi G, Wieselmann G, Altziebler S et al. Erectile dysfunction in patients with type I diabetes mellitus. Wien Med Wochenschr 1995; 145: 584-586.
17. Klein R, Klein BE, Lee KE, Moss SE, Cruickshanks KJ. Prevalence of self-reported erectile dysfunction in people with long term IDDM. Diabetes Care 1996; 19: 135-141.
18. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000; 163: 460-463.
19. Fedele D, Coscelli C, Cucinotta D, Forti G, Santeusanio F, Viaggi S et al. Incidence of erectile dysfunction in Italian men with diabetes. J Urol 2001; 166: 1368-1371.
20. Bancroft J, Wu FC. Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 1983; 12: 59-66.
21. Buvat J, Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol 1997; 158: 1768-1769.
22. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Int Med 2003; 139: 161-168.
23. Baskin HJ. Endocrinologic evaluation of impotence. South Med J 1989; 82: 446-449.
24. Bodie J, Lewis J, Schow D, Monga M. Laboratory evaluation of erectile dysfunction: an evidence based approach. J Urol 2003; 169: 2262-2264.
25. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile dysfunction (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
26. Fonseca V, Seftel A, Denne J, Fredlund P. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 2004; 47: 1914-1923.
27. Pontiroli AE, Pizzocri P, Koprivec D, Vedani P, Marchi M, Arcelloni C et al. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 2004; 150: 195-200.
28. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978-2984.